Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Multiple Sclerosis Drugs Market Research Reports

Titlepublishedprice

Multiple Sclerosis -Epidemiology Forecast to 2025

By Delve Insight
"...... prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Multiple Sclerosis . The report is built ......"
01-Nov-2017$2750

Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast - 2025

By Delve Insight
"...... the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and c......"
01-Nov-2017$5750

Global Multiple Sclerosis Drugs Market Professional Survey Report 2017

By QYResearch Group
"...... anufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Biogen - Teva Pharmaceutical - Merck KGaA - Novartis - Bayer - Sanofi - Acorda Therapeu......"
01-Nov-2017$3500

Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Relapsing Multiple Sclerosis (RMS) which can......"
01-Nov-2017$1500

EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2026

By GlobalData
"...... scle weakness, weak reflexes, tremor, muscle spasm, prolonged double vision, slurred speech, and balance problems. It can occur at any age, but commonly affects people of ages 15-60 years. Women are about twice as likely as men to develop this diseas......"
01-Nov-2017$3995

Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... tion of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Secondary Progress......"
01-Nov-2017$2000

Global Multiple Sclerosis Partnering 2010 to 2017

By Current Partnering
"...... • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals ......"
01-Nov-2017$1495

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2017

By Delve Insight
"...... vities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Primary Progressive Multiple Sclerosis (PPMS) by development stage, therapy type, route of administration and molecule type is ......"
01-Nov-2017$1250

Relapsing Multiple Sclerosis (RMS) - Pipeline Insight, 2017

By Delve Insight
"...... inical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Relapsing Multiple Sclerosis (RMS) by development stage, therapy type, route of administration and molecule type is also covered in the report. It al......"
01-Nov-2017$1250

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2017

By Delve Insight
"...... activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Secondary Progressive Multiple Sclerosis (SPMS) by development stage, therapy type, route of administration and molecule ty......"
01-Nov-2017$1250

Avail upto 25% Discount on below Publisher Reports.